Abstract 5362: Molecular profiling of SW-682, a pan-TEAD inhibitor, as monotherapy and in combination with other treatments across tumor types
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Somdutta Saha, Veronica Jové, Amelia Schirmer, Lorne Celentano, Alma Chanelo, Connor Smith, Sarah Ahn, Jim Smothers, Wenlin Shao, Tai-An Lin, Paula Miliani de Marval, Lei Chen, Robert Dubose
Institution: SpringWorks Therapeutics (United States)
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409633206